Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Apexbio Technology LLC Risedronate Sodium 115436-72-1 1g
Supplier: Apexbio Technology LLC A52931000
Risedronate Sodium (115436-72-1) is a small-molecule inhibitor targeting farnesyl diphosphate (FPP) synthase It is designed to block FPP synthase thereby interfering with the mevalonate pathway and decreasing downstream protein prenylation necessary for cellular proliferation and survival Risedronate Sodium exerts its biological activity primarily through inhibition of FPP synthase leading to antiproliferative and proapoptotic effects in multiple tumor cell lines Additionally it modulates bone metabolism by suppressing osteoclast-mediated bone resorption Based on these pharmacological properties Risedronate Sodium holds research potential in tumor cell biology apoptosis pathways osteoporosis and metabolic bone disease models
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?